4 Mild-Weather Havens To Escape Snowy Winters https://t.co/CfL2goV0gz (Photo: Getty Images) https://t.co/KhLn7d7OoB ...

5 New Trains You’ll Want To Ride Across Europe In 2026 https://t.co/sTelTx6w90Photo: Getty Images https://t.co/fDMpi6ZNAy ...

Company Overview - Bristol Myers Squibb is one of the world's largest pharmaceutical companies, known for its long and successful track record in a highly competitive sector with high drug development costs [2] - The company is currently focusing on cardiovascular, cancer, and immune-related medicines, which are significant healthcare opportunities, despite the market's current fascination with GLP-1 weight-loss drugs [4] Financial Performance - The stock is approximately 25% below its late 2022 highs, presenting a potential recovery opportunity alongside a dividend yield of 4%, which is above the average pharmaceutical stock yield of 1.7% [5] - The payout ratio for dividends is around 70%, indicating a sustainable dividend policy, as the company has a history of regularly increasing dividends and maintaining them during tough times [5] - Key financial metrics include a market cap of $127 billion, a gross margin of 65.89%, and a current stock price of $62.37, with a day's range of $61.18 to $62.67 [6][7] Patent and Product Pipeline - Bristol Myers Squibb's Opdivo cancer drug is set to lose patent protection in 2028, raising investor concerns; however, the company is exploring alternative delivery methods to potentially extend patent protections [7] - The company has a pipeline of other drugs in development, demonstrating its ability to manage patent expirations, which are a normal aspect of the pharmaceutical business [8] Investment Opportunity - The current market conditions present an opportunity to invest in an out-of-favor stock with a relatively high yield, allowing for potential growth through dividend reinvestment [9] - While Bristol Myers Squibb should not be the sole investment, it can serve as a strong foundation for a diversified portfolio, enabling investors to take on more risk in other areas [9]

Core Insights - Sweetgreen's performance in 2025 was significantly poor, with comparable sales declining 11.5% in Q4 and total revenue falling 3.5% to $155.2 million, missing estimates on both fronts [1][2] - The company is projecting a challenging 2026, with guidance indicating comparable sales between -2% and -4% and a restaurant-level profit margin compressing to 14.2%-14.7% [1][2] Financial Performance - In 2024, Sweetgreen experienced a 6% increase in comparable sales and reported adjusted EBITDA of $18.7 million, but the stock has since plummeted 87% from its peak in late 2024 [2] - The company finished 2025 with a same-store sales decline of 7.9% and a revenue increase of only 0.4%, indicating a significant downturn compared to other fast-casual chains [6] Challenges Faced - Factors contributing to Sweetgreen's decline include setbacks from LA wildfires and a loss of loyalty members due to a change in its subscription model [4] - The company has faced criticism regarding high food prices and poor value perception, which have negatively impacted customer loyalty [6] Strategic Moves - Sweetgreen announced the sale of its Spyce business, which includes the Infinite Kitchen automation system, to raise cash while retaining usage rights [5] - The introduction of wraps, a new menu item, is seen as a potential strategy to improve sales and address price perception issues, with initial tests underway in select locations [7][8][9] Market Outlook - Despite the challenges, Sweetgreen's stock valuation has dropped significantly, trading at a price-to-sales ratio of just 1, suggesting that the market may be underestimating the potential for recovery [11][12] - A modest improvement in 2026 could lead to a positive stock response, with wraps potentially serving as a catalyst for growth [13]

Core Viewpoint - Shares of Phillips 66 (PSX) have performed well over the past year, gaining approximately 20% due to improvements in the refining environment, despite challenges faced by its chemicals unit [1] Group 1: Company Performance - Phillips 66 has seen a 20% increase in share value over the past year [1] - The company has benefited from an improved refining environment [1] - The chemicals unit of Phillips 66 is currently struggling [1]

If they get Gainzy we send the seal time CT after IranThreadguyFrankRasmrCapoSize Chad ...

RT Chun (@satofishi)Imagine if this regime had nuclear weapons…They hate civilization, and Dubai is a symbol of civilization in the Arab world. ...

农林牧渔 2026 年 03 月 01 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -10% 0% 10% 19% 29% 38% 2025-03 2025-07 2025-11 农林牧渔 沪深300 相关研究报告 《备货进入尾声支撑走弱，降重有限 +大猪压力未释节后猪价承压—行业 点评报告》-2026.2.24 《一号文件聚焦农业现代化"量化落 地"，猪价节前走弱节后面临较大压 力—行业周报》-2026.2.8 《二育由惜售转出栏但去化有限，节 后猪价回落风险加大—行业周报》- 2026.2.1 10 体重回补二育退潮节后猪价下探，能繁与生产效率 指向全年偏松 ——行业周报 陈雪丽（分析师） chenxueli@kysec.cn 证书编号：S0790520030001 周观察：体重回补二育退潮节后猪价下探，能繁与生产效率指向全年偏松 体重回补叠加二育退潮节后猪价下探，能繁与生产效率指向 2026 全年偏松。据 涌益咨询，截至 2026 年 2 月 27 日，全国生猪均价 10.84 元/公斤，周环比-0.82 元/公斤，本周猪价在小年前备货博弈下走弱。节后我们重点关注体重、二育、 冻品三大抓手进 ...

Email：fengsheng@zts.com.cn 执业证书编号：S0740523020004 Email：hejy02@zts.com.cn 汽车零部件 执业证书编号：S0740524040002 Email：yangshuai01@zts.com.cn 执业证书编号：S0740519050004 | 增持（维持） 评级： | | 公司盈利预测及估值 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | 指标 | | 2023A | 2024A | 2025E | 2026E | 2027E | | 分析师：冯胜 | 营业收入（百万元） | | 16,207 | 16,264 | 16,451 | 18,662 | 21,186 | | | 增长率 yoy% | | -1% | 0% | 1% | 13% | 14% | | 执业证书编号：S0740519050004 | 归母净利润（百万元） | | 727 | 653 | 898 | 1,059 | 1,241 | | Email：fengsheng@zts.com.cn | ...

股 票 研 具身模型 Pi 06 鲁棒性大幅提升，国内人 形初创百亿估值俱乐部增加至 6 家 机器人行业周报 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 肖群稀(分析师) | 0755-23976830 | xiaoqunxi@gtht.com | S0880522120001 | | 李启文(分析师) | 021-38038435 | liqiwen@gtht.com | S0880524060001 | 本报告导读： 请务必阅读正文之后的免责条款部分 究 行 业 Pi 最新的具身智能基础模型 Pi 06 在洗衣与打包场景中取得优异成绩， 英伟达 DreamDojo 破除机器人实操训练数据不足瓶颈，千寻智能、智平 方、因时机器人等多家具身智能企业完成大额融资。 投资要点： [Table_Report] 相关报告 机器人《阿里、小米相继发布开源具身智能大模 型，人形机器人"大脑"有望突破》2026.02.22 机器人《春晚上的机器人：技术跃迁与产业拐 点》2026.02.21 机器人《马斯克将 Optimus 上升至星级 ...